NAFLD
Meeting category
Date(s)
26 May 2023 - 27 May 2023
Location
Barcelona, Spain
Meeting type
Hybrid Workshop
Organizer

Innovations in NAFLD Care Workshop 2023

Related Enduring Materials

Enduring Materials
Innovations in NAFLD Care Workshop (INCBCN) 2024

To read about and register for INCBCN 2023 please click here: https://academicmedicaleducation.com/meeting/innovations-nafld-care-workshop-2024

Virtual Program Book INCBCN 2023
Virtual Abstract Book INCBCN 2023
Program

Day 1 - Friday, 26 May 2023

Session 1: The Fatal Triple and End-Organ Injury -
Chairs
Jörn M. Schattenberg, MD
Saarland University Medical Center, Germany
A.G (Onno) Holleboom, MD, PhD
Amsterdam UMC, the Netherlands
14:10
Epidemic Burden of NAFLD and Cancer
Harriet Rumgay, PhD
International Agency for Research on Cancer (World Health Organization), United Kingdom
14:35
The Duple - NAFLD and Social Drinking
Ramon Bataller, MD, PhD
Hospital Clinic, Spain
15:00
Abstract Oral Presentation #6: Prevalence of Liver Fibrosis and Cirrhosis in the German Disease Management Program for Type 2 Diabetes.
Dr. Maurice Michel
University Medical Center Mainz
15:10
Panel Discussion - Preventive Hepatology
Maru Rinella, MD, FAASLD
University of Chicago Medicine, United States
Naim Alkhouri, MD
Arizona Liver Health, United States
Shira Zelber-Sagi, BSc, RD, PhD
University of Haifa / The Tel-Aviv Medical Center, Israel
Coffee Break
Session 2: Panel Discussion: Future Role of Endocrinologists and Diabetologists in the Early Diagnosis and Management of NASH -
Chairs
Kenneth Cusi, MD, FACP, FACE
The University of Florida, United States
16:10
Panel members
Didac Mauricio, MD, PhD
Hospital de la Santa Creu i Sant Pau CIBERDEM/University of Vic & Central University of Catalonia, Spain
Núria Alonso, MD, PhD
Germans Trias i Pujol Hospital in Badalona, Barcelona, Spain / Autonomous University of Barcelona (UAB), Spain
Francisco Javier Escalada, MD
Clínica Universidad de Navarra, Pamplona / University of Navarra, Spain
Discussion
Patient Organization Session: Supporting Patient Care Pathways -
Chairs
Mazen Noureddin, MD, MHSc
Houston Methodist Hospital, United States.
Juan M. Pericàs, MD, MPH, PhD
The Vall d'Hebron University Hospital, Spain
17:10
Roundtable Discussion
Juan Mendive, MD, PhD
WONCA and ESPCG, Spain
Yiannoula Koulla
Cyprus Liver Patients Association / European Liver Patients’ Association (ELPA), Cyprus
17:40
End of Plenary Program - Day 1
Poster Viewing & Welcome Reception
Workshop Informal Dinner

Day 2 - Saturday, 27 May 2023

Session 3: NAFLD Diagnostics: Overcoming the Challenges -
Chairs
Maru Rinella, MD, FAASLD
University of Chicago Medicine, United States
Naim Alkhouri, MD
Arizona Liver Health, United States
9:00
Automation, Artificial Intelligence and Machine Learning for Patient Identification and Risk Stratification
Alina Allen, MD
Mayo Clinic Rochester, United States
9:40
How to Overcome Barriers of Implementation - Bridging the Gap Between Science and Current Care Pathways
Mazen Noureddin, MD, MHSc
Houston Methodist Hospital, United States.
10:00
Abstract Oral Presentation #11: Establishing a Clinical Research Network for a Platform Trial in Non-alcoholic Steatohepatitis
Dr. Elena Sena
VHIR
Discussion
Coffee Break & Networking
Industry Session: Industry Views on Referral Pathways -
Chairs
Alina Allen, MD
Mayo Clinic Rochester, United States
Ramon Bataller, MD, PhD
Hospital Clinic, Spain
10:55
Panel Discussion
Peter Rydqvist, MSc, PharmD
Madrigal Pharmaceuticals, Sweden
Jeppe Zacho MD, PhD
Global Medical Affairs NASH / Novo Nordisk A/S, Denmark
Laurent Sandrin, PhD
Echosens, France
Diogo Ferrinho,PharmD
GSK, United Kingdom
Session 4: NAFLD Treatment and Care -
Chairs
Jörn M. Schattenberg, MD
Saarland University Medical Center, Germany
Zobair M. Younossi, MD, MPH, FACG, FACP, AGAF, FAASLD
The Global NASH Council / Beatty Liver and Obesity Research, Inova Health System, United States
11:35
Debate: Being Vegetarian will Cure NAFLD
For the Proposition
Shira Zelber-Sagi, BSc, RD, PhD
University of Haifa / The Tel-Aviv Medical Center, Israel
Against the Proposition
Camilla Dalby Hansen, MD
Odense University Hospital, Denmark
12:05
Behavioral Interventions
A.G (Onno) Holleboom, MD, PhD
Amsterdam UMC, the Netherlands
12:25
Medical Therapy in the Near Future
Stephen Harrison, MD, FACP, FAASLD
University of Oxford / Pinnacle Clinical Research / Summit Clinical Research, United Kingdom / United States
12:45
Abstract Oral Presentation #7: Social Jetlag and Mediterranean Diet Adherence are Associated with Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
Mr. Gabriele Castelnuovo
University Of Turin
12:55
Abstract Oral Presentation #4: Time Restricted Feeding for the Management of Non-Alcoholic Fatty Liver Disease: Interim Analysis from a Randomized, Placebo-Controlled Interventional Study
Dr. Angelo Armandi
University Of Turin
Discussion
Lunch Break
Session 5: Health Equity in NAFLD -
Chairs
Jeffrey V. Lazarus, PhD, MIH, MA
Barcelona Institute for Global Health (ISGlobal), Spain / CUNY Graduate School of Public Health and Health Policy, United States
Shira Zelber-Sagi, BSc, RD, PhD
University of Haifa / The Tel-Aviv Medical Center, Israel
14:25
Engaging with Payers and Regulators
Zobair M. Younossi, MD, MPH, FACG, FACP, AGAF, FAASLD
The Global NASH Council / Beatty Liver and Obesity Research, Inova Health System, United States
14:40
Fatty Liver Disease - Socio Economic Status
Juan M. Pericàs, MD, MPH, PhD
The Vall d'Hebron University Hospital, Spain
14:55
NAFLD in Women: Risks and Interventions
Patrizia Carrieri, PhD
National Institute of Health and Medical Research (INSERM), SESSTIM, France
15:10
Abstract Oral Presentation #5: A Global Survey of Health Care Workers Awareness Of Non-alcoholic Fatty Liver Disease
Mr. Stan Driessen
Amsterdam UMC
Discussion
Coffee Break & Networking
Roundtable Discussion - Moving the Field Forward -
Chairs
Jeffrey V. Lazarus, PhD, MIH, MA
Barcelona Institute for Global Health (ISGlobal), Spain / CUNY Graduate School of Public Health and Health Policy, United States
Patrizia Carrieri, PhD
National Institute of Health and Medical Research (INSERM), SESSTIM, France
Panel Discussion
Ben Abbott, PhD
Springer Nature, United Kingdom
Mazen Noureddin, MD, MHSc
Houston Methodist Hospital, United States.
Overview
Welcome
NAFLD 2023



The Innovations in NAFLD Care (INCBCN) Workshop 2023 took place as a hybrid workshop in Barcelona, Spain, from 26-27 May 2023. Delegates were able to attend either in person in Barcelona or virtually from their computer.

This workshop was the third meeting in the Innovations in NAFLD Care Series. The second was the Innovations in NAFLD Care Webinar 2022, held on 6 May 2022 - 7 May 2022. 

Non-alcoholic fatty liver disease (NAFLD) is estimated to affect 33% of the world’s population. Given the association between NAFLD and the growing global epidemics of obesity and type 2 diabetes, this number is expected to increase.

Despite this high prevalence, there remain challenges in screening, as only a minority of cases are diagnosed and correctly treated. Therefore, there is a growing need to design and implement comprehensive models of care. 

The cascade of care for the diagnosis and treatment of NAFLD requires a multidisciplinary approach, with the development of patient-centric structures and systems that facilitate the coordination and integration of services delivered at different levels of healthcare systems.

This workshop provides a platform to bring together the relevant stakeholders and patients to optimize NAFLD care.

The 2-day program explores the different perspectives that healthcare professionals and patients with NAFLD face daily. It will highlight where healthcare providers and policy-makers can implement the most comprehensive models of NAFLD care.

NASH-NIT Real-World-Evidence Summit

The NASH-NITs Real-World-Evidence Summit featured state-of-the-art lectures on the use of real-world evidence for the proper diagnosis of NASH using NITs. The summit was hosted in Barcelona on 26 May as a pre-workshop to the 2nd edition of the “Innovations in NAFLD Care workshop”. The summit was a half-day hybrid summit, where ample time was reserved for debates and panel discussions to exchange knowledge and reinforce the implementation of real-world evidence for the screening, identification, and diagnosis of NAFLD/NASH.

Organizing Committee
What's New?
  • We are delighted to share a new paper, conceived from key findings of the inaugural International Workshop on NAFLD Care, and invite you to join this year’s exciting edition! https://lnkd.in/e8Ep3DJM
  • Please subscribe to our newsletter to receive updates related to this program.

  • Hotel: Sercotel Caspe in Barcelona, Spain (previously known as Ayre Hotel Caspe)

Venue
The workshop will take place in Barcelona, Spain.
Sercotel Caspe (previously known as Ayre Hotel Caspe)
Caspe 103
08013, Barcelona
Spain
https://sercotelcaspebarcelona.com-hotel.com/
COVID-19 Update
Responding to the changing COVID-19 situation, the Innovations in Non-alcoholic Fatty Liver Disease (NAFLD) Care Workshop will be held as a hybrid meeting allowing both in-person and virtual attendance. This workshop format is an optimal solution in light of the current circumstances.

We are available to answer any questions or concerns that you may have about your participation. For more information, please contact Eva Vamvounaki via eva.vamvounaki@amededu.com.
Who Should Attend
- Hepatologists
- Diabetologists
- Endocrinologists
- Obesity experts
- Internal medicine specialists
- Gastroenterologists
- Primary care physicians
- Dieticians
- Nurses
- Physiotherapists
- Policymakers
- Public health officials
- Patient advocates
Meeting Objectives
The workshop aims to:
- Gather patients and leading experts from different disciplines involved in NAFLD care;
- Share the knowledge that exists in different fields and healthcare facilities; and
- Raise awareness and support the implementation of multidisciplinary management of NAFLD.
Learning Objectives
After participating in this workshop, participants will be able to:
- Define the epidemiology of NAFLD and its interplay with other cardio-metabolic complications;
- Describe clinical care pathways for the risk stratification and management of NAFLD patients;
- Evaluate weight management in patients with NAFLD;
- Reflect on the implementation of comprehensive models of care for NAFLD/NASH; and
- Classify pharmacotherapeutics used for obesity, diabetes, and those in the pipeline for NASH.
Certificate of Attendance
A certificate of attendance will be sent to participants after they successfully complete the program and post-meeting survey.
Language
The official language of the workshop is English.
Translation will not be provided.
Enduring Materials
Enduring materials will be available shortly after the conclusion of the workshop.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Academic Medical Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Academic Medical Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the workshop participants agree that the organizers do not accept responsibility for medical, travel or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Registration
Registration for the Innovations in NAFLD Care Workshop 2023 is open ro view on demand.
Fees and Conditions

Regular Delegates -
In-Person Attendance

Regular Delegates -
Virtual Attendance

Industry*

Early Fee (payment before/on 25 September 2022)

€395.00

€197.50

€1395.00

Standard Fee (payment before/on 21 May 2023)

€795.00

€397.50

€1795.00

Onsite/Same Day Fee (payment on/after 22 May 2023) 

€995.00

€497.50

€1995.00

Discounts

Early-career investigators and/or academia from Resource-Limited Settings (RLS)**, NGO representatives, government representatives, and community advocates

50% Off Current Regular Delegates Fee

Representatives of sponsoring industry / endorsing organizations

Please contact the conference secretariat

* Industry representatives may receive a discount based on the level of support provided to the event. For more support and registration information, please contact us via Rikke.Rode@amededu.com.

** Countries included in the low-income and lower middle-income economies of the World Bank Classification.

If you have financial concerns or are eligible for a discount, please contact the conference secretariat via daria.bohdanova@amededu.com

Important
  • AME (Academic Medical Education) reserves the right to cancel improper registrations. Claims for a refund will not be honored.

  • We strongly advise that you register early to ensure your registration.

  • Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.

Cancellation Policy
In case of cancellation, the following refunds are applicable:

- Cancellation before/on 25 April 2023: 50% refund (minus an administration fee of €40)
- Cancellation after 26 April 2023: Unfortunately, no refund will be given

If you are unable to attend the conference, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate before 12 May 2023. A statement (email/letter) of cancellation must be sent to AME.
Early-Career Investigators / Academia from Resource-limited Settings (RLS)
We are pleased to offer free registration to early-career investigators and academia from low-income and lower-middle-income countries with an accepted abstract and a 50% discount on the registration fee without an accepted abstract.

IMPORTANT: Free registration is offered to the presenting author only.

To be eligible as an early-career investigator, one should either be a current Master/PhD student or have obtained an MD/PharmD/PhD degree in the last five years. An application form needs to be completed by a supervisor and received by the Academic Medical Education secretariat at least two weeks prior to the start of the workshop. Academic Medical Education will contact the early-career investigator with instructions regarding the registration procedure.
Group Registration
For registration of groups larger than 5 participants, please contact Daria Bohdanova at daria.bohdanova@amededu.com to use the Group Registration Portal.
Payment
By credit card only: online or by written authorization (see online registration).

Please contact the conference secretariat via daria.bohdanova@amededu.com if you need to make alternative arrangements.
Registration Fee Includes
- Access to all scientific sessions
- Access to enduring materials
- (Virtual) workshop materials
Liability and Insurance
By registering for the conference, participants agree that the organizers do not accept responsibility for medical, travel, or personal insurance. Participants are advised to take out their own insurance policies.
Media Registration
In order to register as a media participant for the Conference, the conference secretariat needs to receive:

1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop

A fee waiver may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.

We would like to receive a copy of your workshop report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the Workshop. Media representatives are kindly requested to register by sending the above-mentioned information to info@amededu.com.

Important: Media is restricted to the written press. Recording on film or photo is not allowed. Virology Education will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2022 embargo policy.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The organizing secretariat of this workshop, Academic Medical Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Academic Medical Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop. In case of cancellation of the meeting due to unforeseen circumstances, Academic Medical Education cannot be held responsible for expenses made for travel, accommodation, visa applications, etc.
NIT Summit

Registration for the NASH-NITs Real-World-Evidence Summit is closed.

About

The NASH-NITs Real-World-Evidence Summit was a half-day hybrid summit, where ample time was reserved for debates and panel discussions to exchange knowledge and reinforce the implementation of real-world evidence for the screening, identification, and diagnosis of NAFLD/NASH.

The summit was hosted in Barcelona on 26 May as a pre-workshop to the 2nd edition of the Innovations in NAFLD Care Workshop.

The overarching goal of the NASH-NITs Real-World-Evidence Summit was to promote a heterogeneous use of NITs using real-world data to accelerate the identification of undiagnosed patients and the risk factors for developing NAFLD and NASH.

The summit enabled both on-site participation and virtual access to the audience to broadly disseminate teaching material and extend the outreach far beyond the conference walls. Enduring materials were posted on the AME online platform, and publicly accessible on-demand to further support knowledge retention and increase the educational impact.

Program

All times are in Central European Summer Time (CEST). If you would like another time zone, this might be of use to you: https://www.worldtimebuddy.com/ 

Day 1 - Friday, 26 May 2023

Non-invasive Testing - Opportunities and Challenges -
Chairs
Naim Alkhouri, MD
Arizona Liver Health, United States
Jörn M. Schattenberg, MD
Saarland University Medical Center, Germany
10:10
101 Biomarker in Fibrotic Liver Disease OR the Armamentarium of Non-invasive Test to Stage Liver Disease
Jörn M. Schattenberg, MD
Saarland University Medical Center, Germany
10:35
Use and Pitfalls of NITs in Patients with Diabetes
Alina Allen, MD
Mayo Clinic Rochester, United States
Discussion
Coffee Break
Practical Session - 11:30
11:30
"Hands on Training" with Transient Elastography
End of Summit/ Lunch
14:00
Opening of Innovations in NAFLD care (INCBCN)
Committees
Program Directors
Organizing Committee
The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.
Scientific Committee
The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.
Support
Support our Initiative

Financial backing helps us deliver an impactful meeting experience for the benefit of healthcare professionals and community representatives involved in the Innovative Models in Non-Alcoholic Fatty Liver Disease (NAFLD).
 
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
 
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Rikke Puggaard-Rode at Rikke.Rode@amededu.com or call +31 30 230 7149

By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

Symposium opportunities

  • Non-commercial interviews with company representatives
  • Verbal acknowledgment during the program 
  • Discounted and complimentary registrations for your representatives
  • Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
  • Company acknowledgment on printed meeting materials including but not limited to banners and the program book
  • Digital and printed advertising opportunities 
  • Social media shout-outs
  • Logo on the conference bag

*Subject to the support level

Partners
Abstract
Abstract
  • Abstract Submission is now closed.
     
  • NAFLD Workshop 2023 accepts new original data as well as encored abstracts. All abstracts must focus on healthcare challenges related to NAFLD Care and contain up-to-date information at the time of the meeting. 
     
  • Registration fees are waived for healthcare professionals from RLS and early-career professionals with an accepted abstract. A 50% discount is offered to healthcare professionals from RLS and early-career professionals without an accepted abstract. The requirements for the application are specified under "Registration". 

For purposes of review and programming, abstracts are divided into topical categories. The selection of the most appropriate category is important as it determines who reviews your abstract. The Review Committee reserves the right to reassign your abstract to a more appropriate category. Abstracts will be accepted either for oral or poster presentations.

Abstract Categories:

  • Epidemiology of NAFLD
  • Economic and clinical burden of NAFLD
  • Non-Invasive Tests for NAFLD
  • Models of Care / Multidisciplinary Approaches
  • Management: Lifestyle interventions and pharmacotherapeutics
  • Application of digital tools and artificial intelligence in NAFLD care
Terms & Conditions

By submitting an abstract to a meeting organized Academic Medical Education BV (AME), the abstract submitter hereby agrees to the terms and conditions.

The terms and conditions can be viewed here.

General Guidelines
Abstracts should contain the following four components:

- Background: A concise statement of the issue under investigation or a hypothesis;

- Material and Methods: The experimental methods used (including the statistical analyses employed);

- Results: Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);

- Conclusions: A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the meeting and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.
Abstract Topics
• Epidemiology of NAFLD;
• Economic and clinical burden of NAFLD;
• Non-Invasive Tests for NAFLD;
• Models of Care / Multidisciplinary Approaches;
• Management: Lifestyle interventions and pharmacotherapeutics;
• Application of digital tools and artificial intelligence in NAFLD care.
Abstract Submission
Abstract Submission is now closed.
Poster Presentation Instructions for Virtual Meeting
- Posters should be prepared in PDF.
- The measurements of your poster should not exceed two Letter/ A4 format pages, make sure the quality of your poster is good (at least 300 dpi).
- Please display the number of your poster in the upper right corner of your poster.
- If you wish to allow people to reach out directly to you, please display your contact details on your poster.
- In addition, you are asked to make a short recording (max. 3 min) of your presentation with a few slides using PowerPoint. You can record this video directly from PowerPoint.
- Your poster and the short video will be displayed in the virtual Poster Gallery throughout the conference and will be available on our website after the conference days.
Poster Presentation Instructions for Face-to-Face Meeting
Posters need to meet the following dimensions: A0 size (approx 33" width x 47" height), portrait format

Poster presenters are requested to stand near their posters during the poster session.

We advise you to prepare hand-outs of your poster on Letter or A4 format.

Please hang your posters as early as possible. All posters must be displayed from the opening session to the closure of the meeting.

Pushpins and/or velcro will be provided.
Abstract Publication
Accepted abstracts will be published in the Abstract Book. This will be distributed during the meeting and will be available as enduring material after the meeting has concluded. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.

VE and AME is the sole copyright holder of the conference abstract book as a whole. The abstract authors will retain any and all copyright over their individual abstracts. Information on copyright can be viewed in the abstract submission terms and conditions (see 'Terms and Conditions' above).
Media
Invitation to Join the Innovations in NAFLD Care Workshop | 26-27 May 2023
Invitation from Jeffrey Lazarus, PhD, MIH, MA, Barcelona Institute for Global Health (ISGlobal), Spain and Jörn Schattenberg, MD, Johannes Gutenberg-Universität Mainz, Germany
Photo Gallery
Image
NAFLD 2023
Image
NAFLD 2023
Image
NAFLD 2023
Image
NAFLD 2023
Image
NAFLD 2023
Image
NAFLD 2023
Image
NAFLD 2023
Image
NAFLD 2023
Image
NAFLD 2023
Image
NAFLD 2023
Image
NAFLD 2023
Image
NAFLD 2023
Image
NAFLD 2023
Language